Volume
20 Number 7
July 2018
.
Home > Publications > Brain Tumor Reports > Volume 20, Year 2018 > Number 7, July
GLIOMAS
└
BRAIN
STEM GLIOMAS
└└
Diffuse
intrinsic pontine gliomas
└
HIGH-GRADE
GLIOMAS
└
LOW-GRADE
GLIOMAS
DIFFUSE
ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
└
GLIOBLASTOMA
.
Guerreiro Stucklin AS, Grotzer MA.
Cerebellar tumors.
Handb Clin Neurol. 2018;155:289-299. doi:
10.1016/B978-0-444-64189-2.00019-6.
Source
|
Abstract
| Full
text |
Similar
articles
.
Gillespie S, Monje M.
An Active Role for Neurons in
Glioma Progression: Making Sense of Scherer's Structures.
Neuro
Oncol. 2018 May 17. doi: 10.1093/neuonc/noy083. [Epub ahead of
print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Li Z, Xia Y, Bu X, Yang D, Yuan Y, Guo X, Zhang G, Wang Z, Jiao J.
Effects of valproic acid on the susceptibility of human
glioma stem cells for TMZ and ACNU.
Oncol Lett. 2018
Jun;15(6):9877-9883. doi: 10.3892/ol.2018.8551. Epub 2018 Apr 20.
Source
|
Abstract
| Full
text |
Similar
articles
.
Pyka T, Hiob D, Preibisch C, Gempt J, Wiestler B, Schlegel J,
Straube C, Zimmer C.
Diagnosis of glioma recurrence using
multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI.
Eur
J Radiol. 2018 Jun;103:32-37. doi: 10.1016/j.ejrad.2018.04.003.
Epub 2018 Apr 4.
Source
|
Abstract
| Full
text |
Similar
articles
.
Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M,
Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M,
Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda
M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F,
Gandola L.
Correction to: Results of nimotuzumab and
vinorelbine, radiation and re-irradiation for diffuse pontine
glioma in childhood.
J Neurooncol. 2018 May 16. doi:
10.1007/s11060-018-2893-6. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB,
Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee
IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W,
Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ,
Gruber HE, Das A, Walbert T.
Durable Complete Responses
in Some Recurrent High Grade Glioma Patients Treated with Toca 511
& Toca FC.
Neuro Oncol. 2018 May 12. doi:
10.1093/neuonc/noy075. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Mantica M, Pritchard A, Lieberman F, Drappatz J.
Retrospective
study of nivolumab for patients with recurrent high grade gliomas.
J Neurooncol. 2018 May 19. doi:
10.1007/s11060-018-2907-4. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Zhao H, Liu S, Jiang C, Li X, Tang S.
[Clinical efficacy
of stereotactic radiation therapy combined with temozolomide on
recurrent brain glioma].
Zhong Nan Da Xue Xue Bao Yi Xue
Ban. 2018 Apr 28;43(4):394-397. doi:
10.11817/j.issn.1672-7347.2018.04.009. Chinese.
Source
|
Abstract
| Full
text |
Similar
articles
.
Shah AS, Nicoletti LK, Kurtovic E, Tsien CI, Benzinger TLS,
Chicoine MR.
Progression of Low-Grade Glioma During
Pregnancy With Subsequent Regression Postpartum Without
Treatment-A Case Report.
Neurosurgery. 2018 May 21. doi:
10.1093/neuros/nyy191. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F,
Brachman DG, Werner-Wasik M, Hunter GK, Valeinis E, Hopkins K,
Souhami L, Howard SP, Lieberman FS, Shrieve DC, Wendland MM,
Robinson CG, Zhang P, Corn BW.
Short delay in initiation
of radiotherapy for patients with glioblastoma- effect of
concurrent chemotherapy: a secondary analysis from the NRG
Oncology/Radiation Therapy Oncology Group (RTOG) database.
Neuro
Oncol. 2018 Feb 15. doi: 10.1093/neuonc/noy017. [Epub ahead of
print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Bonomi RE, Kovoor J, Zaki M, Szlaczky M, Christensen M, Kupsky W,
Barger G, Miller S, Dominello MM.
Glioblastoma metastatic
to the ovary, a very different Krukenberg tumor?
Pract
Radiat Oncol. 2018 Apr 7. pii: S1879-8500(18)30119-X. doi:
10.1016/j.prro.2018.04.002. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Frade Porto N, Delgado Fernández J, García Pallero
MLÁ, Penanes Cuesta JR, Pulido Rivas P, Gil Simoes R.
Subcutaneous tissue metastasis from glioblastoma
multiforme: A case report and review of the literature.
Neurocirugia (Astur). 2018 May 16. pii:
S1130-1473(18)30047-2. doi: 10.1016/j.neucir.2018.03.005. [Epub
ahead of print] English, Spanish.
Source
|
Abstract
| Full
text |
Similar
articles
.
Geurts M, van den Bent MJ.
Timing of radiotherapy in
newly diagnosed glioblastoma: no need to rush?
Comment
on: Blumenthal DT et al., Short delay in initiation of
radiotherapy for patients with glioblastoma- effect of concurrent
chemotherapy: a secondary analysis from the NRG Oncology/Radiation
Therapy Oncology Group (RTOG) database. Neuro Oncol. 2018 Feb 15.
doi: 10.1093/neuonc/noy017
Neuro Oncol.
2018 May 15. doi: 10.1093/neuonc/noy065. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Kim SH, Yoo H, Chang JH, Kim CY, Chung DS, Kim SH, Park SH, Lee
YS, Yang SH.
Procarbazine and CCNU Chemotherapy for
Recurrent Glioblastoma with MGMT Promoter Methylation.
J
Korean Med Sci. 2018 May 10;33(24):e167. doi:
10.3346/jkms.2018.33.e167. eCollection 2018 Jun 11.
Source
|
Abstract
| Full
text |
Similar
articles
.
Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS,
Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ,
Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R,
Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA,
Lillehei KO, Mikkelsen T, Walpert T, Abram SR, Brenner AJ, Brem S,
Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC,
Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE,
Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB,
Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ,
Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL,
Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM,
Cloughesy TF, Mulholland P, Bosch ML.
First results on
survival from a large Phase 3 clinical trial of an autologous
dendritic cell vaccine in newly diagnosed glioblastoma.
J
Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6.
Source
|
Abstract
| Full
text |
Similar
articles
.
Lu VM, Goyal A, Vaughan LS, McDonald KL.
The impact of
hyperglycemia on survival in glioblastoma: A systematic review and
meta-analysis.
Clin Neurol Neurosurg. 2018
Jul;170:165-169. doi: 10.1016/j.clineuro.2018.05.020. Epub 2018
May 19.
Source
|
Abstract
| Full
text |
Similar
articles
.
Nguyen B, Samara J, Lee A, Fadia M, Ngu C, Pranavan G.
A
case of subgaleal metastasis from glioblastoma multiforme.
Intern
Med J. 2018 Jun 12;48(6):741-742. doi: 10.1111/imj.13818.
Source
|
Abstract
| Full
text |
Similar
articles
.
Magge RS.
How
Helpful Is Bevacizumab in Recurrent Glioblastoma?
Relias
(AHC Media). 2018 Jan 1.
Comment
on: Wick W, Gorlia T, Bendszus M, et al. Lomustine and bevacizumab
in progressive glioblastoma. N
Engl J Med 2017;377:1954-1963.
Source
|
Abstract
| Full
text |
Similar
articles
.
Mughal AA, Zhang L, Fayzullin A, Server A, Li Y, Wu Y, Glass R,
Meling T, Langmoen IA, Leergaard TB, Vik-Mo EO.
Patterns
of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as
an Invasion-Spared Brain Region.
Neoplasia. 2018 May
21;20(7):643-656. doi: 10.1016/j.neo.2018.04.001. [Epub ahead of
print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M,
Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A,
Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli
E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà
R, Soffietti R, Paiar F.
Single-agent Bevacizumab in
Recurrent Glioblastoma After Second-line Chemotherapy With
Fotemustine: The Experience of the Italian Association of
Neuro-Oncology.
Am J Clin Oncol. 2018 May 18. doi:
10.1097/COC.0000000000000464. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Rigamonti A, Imbesi F, Silvani A, Gaviani P, Agostoni E, Porcu L,
De Simone I, Torri V, Salmaggi A.
Antiepileptic treatment
and survival in newly diagnosed glioblastoma patients:
Retrospective multicentre study in 285 Italian patients.
J
Neurol Sci. 2018 Jul 15;390:14-19. doi: 10.1016/j.jns.2018.04.004.
Epub 2018 Apr 5.
Source
|
Abstract
| Full
text |
Similar
articles
.
Sanai N, Li J, Boerner J, Stark K, Wu J, Kim S, Derogatis A, Mehta
S, Dhruv HD, Heilbrun LK, Berens ME, LoRusso PM.
Phase 0
Trial of AZD1775 in First-Recurrence Glioblastoma Patients.
Clin
Cancer Res. 2018 May 24. doi: 10.1158/1078-0432.CCR-17-3348. [Epub
ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Scoccianti S, Francolini G, Carta GA, Greto D, Detti B,
Simontacchi G, Visani L, Baki M, Poggesi L, Bonomo P, Mangoni M,
Desideri I, Pallotta S, Livi L.
Re-irradiation as salvage
treatment in recurrent glioblastoma: A comprehensive literature
review to provide practical answers to frequently asked questions.
Crit Rev Oncol Hematol. 2018 Jun;126:80-91. doi:
10.1016/j.critrevonc.2018.03.024. Epub 2018 Mar 31.
Source
|
Abstract
| Full
text |
Similar
articles
.
Vengoji R, Macha MA, Batra SK, Shonka NA.
Natural
products: a hope for glioblastoma patients.
Oncotarget.
2018 Apr 24;9(31):22194-22219. doi: 10.18632/oncotarget.25175.
eCollection 2018 Apr 24.
Source
|
Abstract
| Full
text |
Similar
articles
.
Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy
G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS,
Jalali R.
Nomograms based on Pre-operative
Multi-parametric Magnetic Resonance Imaging for Prediction of
Molecular Subgrouping in Medulloblastoma: Results from a
Radiogenomics Study of 111 Patients.
Neuro Oncol. 2018
May 29. doi: 10.1093/neuonc/noy093. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Lassaletta A.
Medulloblastoma in infants: the
never-ending challenge.
Lancet Oncol. 2018
Jun;19(6):720-721. doi: 10.1016/S1470-2045(18)30278-X. Epub 2018
May 16.
Comment
on: Robinson GW et al, Risk-adapted therapy for young children
with medulloblastoma (SJYC07): therapeutic and molecular outcomes
from a multicentre, phase 2 trial. Lancet Oncol. 2018
Jun;19(6):768-784.
Source
|
Abstract
| Full
text |
Similar
articles
.
Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E,
Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques
TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders
AJ, Resnick AC, Massimino M, Garrè ML, Smith H, Capper D,
Pfister SM, Würdinger T, Tam R, Garcia J, Thakur MD, Vassal
G, Grill J, Jaspan T, Varlet P, Jones C.
Molecular,
Pathological, Radiological, and Immune Profiling of Non-brainstem
Pediatric High-Grade Glioma from the HERBY Phase II Randomized
Trial.
Cancer Cell. 2018 May 14;33(5):829-842.e5. doi:
10.1016/j.ccell.2018.04.004.
Source
|
Abstract
| Full
text |
Similar
articles
.
Mascaro-Cordeiro B, Oliveira ID, Tesser-Gamba F, Pavon LF,
Saba-Silva N, Cavalheiro S, Dastoli P, Toledo SRC.
Valproic
acid treatment response in vitro is determined by TP53 status in
medulloblastoma.
Childs Nerv Syst. 2018 May 22. doi:
10.1007/s00381-018-3817-7. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
.
Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM,
Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR,
Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z,
Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T,
Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders
RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.
Risk-adapted therapy for young children with
medulloblastoma (SJYC07): therapeutic and molecular outcomes from
a multicentre, phase 2 trial.
Lancet Oncol. 2018
Jun;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. Epub 2018
May 16.
Source
|
Abstract
| Full
text |
Similar
articles
.
Satyarthee GD, Mahapatra AK.
Pediatric Cerebello-Pontine
Angle Medulloblastoma: A Management Review.
J Pediatr
Neurosci. 2018 Jan-Mar;13(1):125-128. doi: 10.4103/JPN.JPN_90_17.
Source
|
Abstract
| Full
text |
Similar
articles